Literature DB >> 21115726

Getting smart about p21-activated kinases.

Mollie L Kelly1, Jonathan Chernoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21115726      PMCID： PMC3028629          DOI： 10.1128/MCB.01267-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN： 0270-7306            Impact factor:   4.272


× No keyword cloud information.
  10 in total

Review 1.  AMPA receptor trafficking and synaptic plasticity.

Authors:  Roberto Malinow; Robert C Malenka
Journal:  Annu Rev Neurosci       Date:  2002-03-04       Impact factor: 12.449

Review 2.  A tale of two Paks.

Authors:  Luis E Arias-Romero; Jonathan Chernoff
Journal:  Biol Cell       Date:  2008-02       Impact factor: 4.458

3.  Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3.

Authors:  Jinsong Meng; Yanghong Meng; Amanda Hanna; Christopher Janus; Zhengping Jia
Journal:  J Neurosci       Date:  2005-07-13       Impact factor: 6.167

4.  p21-Activated kinases 1 and 3 control brain size through coordinating neuronal complexity and synaptic properties.

Authors:  Wayne Huang; Zikai Zhou; Suhail Asrar; Mark Henkelman; Wei Xie; Zhengping Jia
Journal:  Mol Cell Biol       Date:  2010-11-29       Impact factor: 4.272

5.  Nuclear localization and chromatin targets of p21-activated kinase 1.

Authors:  Rajesh R Singh; Chunying Song; Zhibo Yang; Rakesh Kumar
Journal:  J Biol Chem       Date:  2005-03-03       Impact factor: 5.157

6.  The mental retardation protein PAK3 contributes to synapse formation and plasticity in hippocampus.

Authors:  Bernadett Boda; Stefano Alberi; Irina Nikonenko; Roxanne Node-Langlois; Pascal Jourdain; Marlyse Moosmayer; Lorena Parisi-Jourdain; Dominique Muller
Journal:  J Neurosci       Date:  2004-12-01       Impact factor: 6.167

7.  PAK3 related mental disability: further characterization of the phenotype.

Authors:  Maarit Peippo; Anne M Koivisto; Teppo Särkämö; Marjatta Sipponen; Harriet von Koskull; Tero Ylisaukko-oja; Karola Rehnström; Guy Froyen; Jaakko Ignatius; Irma Järvelä
Journal:  Am J Med Genet A       Date:  2007-10-15       Impact factor: 2.802

Review 8.  PAK signalling in neuronal physiology.

Authors:  Patricia Kreis; Jean-Vianney Barnier
Journal:  Cell Signal       Date:  2008-11-12       Impact factor: 4.315

9.  Regulation of hippocampal long-term potentiation by p21-activated protein kinase 1 (PAK1).

Authors:  Suhail Asrar; Yanghong Meng; Zikai Zhou; Zarko Todorovski; Wayne Wenyin Huang; Zhengping Jia
Journal:  Neuropharmacology       Date:  2008-07-03       Impact factor: 5.250

10.  Interaction with LC8 is required for Pak1 nuclear import and is indispensable for zebrafish development.

Authors:  Christine M Lightcap; Gabor Kari; Luis E Arias-Romero; Jonathan Chernoff; Ulrich Rodeck; John C Williams
Journal:  PLoS One       Date:  2009-06-26       Impact factor: 3.240
  10 in total
  6 in total

1.  Computer-based identification of a novel LIMK1/2 inhibitor that synergizes with salirasib to destabilize the actin cytoskeleton.

Authors:  Efrat Mashiach-Farkash; Roni Rak; Galit Elad-Sfadia; Roni Haklai; Shmuel Carmeli; Yoel Kloog; Haim J Wolfson
Journal:  Oncotarget       Date:  2012-06

2.  Novel LIMK2 Inhibitor Blocks Panc-1 Tumor Growth in a mouse xenograft model.

Authors:  Roni Rak; Roni Haklai; Galit Elad-Tzfadia; Haim J Wolfson; Shmuel Carmeli; Yoel Kloog
Journal:  Oncoscience       Date:  2014-01-01

3.  A Novel Pak1/ATF2/miR-132 Signaling Axis Is Involved in the Hematogenous Metastasis of Gastric Cancer Cells.

Authors:  Funan Liu; Zhenguo Cheng; Xiaodong Li; Yanshu Li; Hongyan Zhang; Jiabin Li; Furong Liu; Huimian Xu; Feng Li
Journal:  Mol Ther Nucleic Acids       Date:  2017-07-08       Impact factor: 8.886

Review 4.  Emerging evidence of the molecular landscape specific for hematogenous metastasis from gastric cancer.

Authors:  Dai Shimizu; Mitsuro Kanda; Yasuhiro Kodera
Journal:  World J Gastrointest Oncol       Date:  2018-06-15

5.  Pressure and stiffness sensing together regulate vascular smooth muscle cell phenotype switching.

Authors:  Pamela Swiatlowska; Brian Sit; Zhen Feng; Emilie Marhuenda; Ioannis Xanthis; Simona Zingaro; Matthew Ward; Xinmiao Zhou; Qingzhong Xiao; Cathy Shanahan; Gareth E Jones; Cheng-Han Yu; Thomas Iskratsch
Journal:  Sci Adv       Date:  2022-04-15       Impact factor: 14.957

6.  PAK2 is an effector of TSC1/2 signaling independent of mTOR and a potential therapeutic target for Tuberous Sclerosis Complex.

Authors:  Maria M Alves; Gwenny M Fuhler; Karla C S Queiroz; Jetse Scholma; Susan Goorden; Jasper Anink; C Arnold Spek; Marianne Hoogeveen-Westerveld; Marco J Bruno; Mark Nellist; Ype Elgersma; Eleonora Aronica; Maikel P Peppelenbosch
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.